-
1
-
-
0036083396
-
The ubiquitinproteasome proteolytic pathway: destruction for the sake of construction
-
Glickman MH and Ciechanover A. The ubiquitinproteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 2002; 82(2):373-428.
-
(2002)
Physiol Rev.
, vol.82
, Issue.2
, pp. 373-428
-
-
Glickman, M.H.1
Ciechanover, A.2
-
3
-
-
3242807547
-
Post-proteasomal antigen processing for major histocompatibility complex class I presentation
-
Rock KL, York IA and Goldberg AL. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat Immunol. 2004; 5(7):670-677.
-
(2004)
Nat Immunol.
, vol.5
, Issue.7
, pp. 670-677
-
-
Rock, K.L.1
York, I.A.2
Goldberg, A.L.3
-
4
-
-
0031973765
-
The ubiquitinproteasome pathway in cancer
-
Spataro V, Norbury C and Harris AL. The ubiquitinproteasome pathway in cancer. Br J Cancer. 1998; 77(3):448-455.
-
(1998)
Br J Cancer.
, vol.77
, Issue.3
, pp. 448-455
-
-
Spataro, V.1
Norbury, C.2
Harris, A.L.3
-
6
-
-
20444433230
-
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
-
Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, San-Miguel JF, Blade J, Boccadoro M, Cavenagh J, Dalton WS, et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med. 2005; 352(24):2487-2498.
-
(2005)
N Engl J Med.
, vol.352
, Issue.24
, pp. 2487-2498
-
-
Richardson, P.G.1
Sonneveld, P.2
Schuster, M.W.3
Irwin, D.4
Stadtmauer, E.A.5
Facon, T.6
Harousseau, J.L.7
Ben-Yehuda, D.8
Lonial, S.9
Goldschmidt, H.10
Reece, D.11
San-Miguel, J.F.12
Blade, J.13
Boccadoro, M.14
Cavenagh, J.15
Dalton, W.S.16
-
7
-
-
50449086728
-
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
-
San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M, Spicka I, Petrucci MT, Palumbo A, Samoilova OS, Dmoszynska A, Abdulkadyrov KM, Schots R, Jiang B, Mateos MV, Anderson KC, et al. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med. 2008; 359(9):906-917.
-
(2008)
N Engl J Med.
, vol.359
, Issue.9
, pp. 906-917
-
-
San Miguel, J.F.1
Schlag, R.2
Khuageva, N.K.3
Dimopoulos, M.A.4
Shpilberg, O.5
Kropff, M.6
Spicka, I.7
Petrucci, M.T.8
Palumbo, A.9
Samoilova, O.S.10
Dmoszynska, A.11
Abdulkadyrov, K.M.12
Schots, R.13
Jiang, B.14
Mateos, M.V.15
Anderson, K.C.16
-
8
-
-
33745728140
-
Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132
-
Crawford LJ, Walker B, Ovaa H, Chauhan D, Anderson KC, Morris TC and Irvine AE. Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132. Cancer Res. 2006; 66(12):6379-6386.
-
(2006)
Cancer Res.
, vol.66
, Issue.12
, pp. 6379-6386
-
-
Crawford, L.J.1
Walker, B.2
Ovaa, H.3
Chauhan, D.4
Anderson, K.C.5
Morris, T.C.6
Irvine, A.E.7
-
9
-
-
22244446505
-
The mammalian unfolded protein response
-
Schroder M and Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005; 74:739-789.
-
(2005)
Annu Rev Biochem.
, vol.74
, pp. 739-789
-
-
Schroder, M.1
Kaufman, R.J.2
-
10
-
-
0037441760
-
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
-
Hideshima T, Mitsiades C, Akiyama M, Hayashi T, Chauhan D, Richardson P, Schlossman R, Podar K, Munshi NC, Mitsiades N and Anderson KC. Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341. Blood. 2003; 101(4):1530-1534.
-
(2003)
Blood.
, vol.101
, Issue.4
, pp. 1530-1534
-
-
Hideshima, T.1
Mitsiades, C.2
Akiyama, M.3
Hayashi, T.4
Chauhan, D.5
Richardson, P.6
Schlossman, R.7
Podar, K.8
Munshi, N.C.9
Mitsiades, N.10
Anderson, K.C.11
-
11
-
-
79952781038
-
Multiple myeloma
-
Palumbo A and Anderson K. Multiple myeloma. N Engl J Med. 2011; 364(11):1046-1060.
-
(2011)
N Engl J Med.
, vol.364
, Issue.11
, pp. 1046-1060
-
-
Palumbo, A.1
Anderson, K.2
-
12
-
-
0026585927
-
Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials
-
Gregory WM, Richards MA and Malpas JS. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. J Clin Oncol. 1992; 10(2):334-342.
-
(1992)
J Clin Oncol.
, vol.10
, Issue.2
, pp. 334-342
-
-
Gregory, W.M.1
Richards, M.A.2
Malpas, J.S.3
-
13
-
-
0347815503
-
Single versus double autologous stem-cell transplantation for multiple myeloma
-
Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, Monconduit M, Hulin C, Caillot D, Bouabdallah R, Voillat L, Sotto JJ, Grosbois B and Bataille R. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med. 2003; 349(26):2495-2502.
-
(2003)
N Engl J Med.
, vol.349
, Issue.26
, pp. 2495-2502
-
-
Attal, M.1
Harousseau, J.L.2
Facon, T.3
Guilhot, F.4
Doyen, C.5
Fuzibet, J.G.6
Monconduit, M.7
Hulin, C.8
Caillot, D.9
Bouabdallah, R.10
Voillat, L.11
Sotto, J.J.12
Grosbois, B.13
Bataille, R.14
-
14
-
-
75649085683
-
Current multiple myeloma treatment strategies with novel agents: a European perspective
-
Ludwig H, Beksac M, Blade J, Boccadoro M, Cavenagh J, Cavo M, Dimopoulos M, Drach J, Einsele H, Facon T, Goldschmidt H, Harousseau JL, Hess U, Ketterer N, Kropff M, Mendeleeva L, et al. Current multiple myeloma treatment strategies with novel agents: a European perspective. Oncologist. 2010; 15(1):6-25.
-
(2010)
Oncologist.
, vol.15
, Issue.1
, pp. 6-25
-
-
Ludwig, H.1
Beksac, M.2
Blade, J.3
Boccadoro, M.4
Cavenagh, J.5
Cavo, M.6
Dimopoulos, M.7
Drach, J.8
Einsele, H.9
Facon, T.10
Goldschmidt, H.11
Harousseau, J.L.12
Hess, U.13
Ketterer, N.14
Kropff, M.15
Mendeleeva, L.16
-
15
-
-
0037973279
-
A phase 2 study of bortezomib in relapsed, refractory myeloma
-
Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med. 2003; 348(26):2609-2617.
-
(2003)
N Engl J Med.
, vol.348
, Issue.26
, pp. 2609-2617
-
-
Richardson, P.G.1
Barlogie, B.2
Berenson, J.3
Singhal, S.4
Jagannath, S.5
Irwin, D.6
Rajkumar, S.V.7
Srkalovic, G.8
Alsina, M.9
Alexanian, R.10
Siegel, D.11
Orlowski, R.Z.12
Kuter, D.13
Limentani, S.A.14
Lee, S.15
Hideshima, T.16
-
16
-
-
0141953292
-
Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells
-
Chauhan D, Li G, Shringarpure R, Podar K, Ohtake Y, Hideshima T and Anderson KC. Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells. Cancer Res. 2003; 63(19):6174-6177.
-
(2003)
Cancer Res.
, vol.63
, Issue.19
, pp. 6174-6177
-
-
Chauhan, D.1
Li, G.2
Shringarpure, R.3
Podar, K.4
Ohtake, Y.5
Hideshima, T.6
Anderson, K.C.7
-
17
-
-
0026674983
-
Peptide transport by the multidrug resistance pump
-
Sharma RC, Inoue S, Roitelman J, Schimke RT and Simoni RD. Peptide transport by the multidrug resistance pump. J Biol Chem. 1992; 267(9):5731-5734.
-
(1992)
J Biol Chem.
, vol.267
, Issue.9
, pp. 5731-5734
-
-
Sharma, R.C.1
Inoue, S.2
Roitelman, J.3
Schimke, R.T.4
Simoni, R.D.5
-
18
-
-
0035866761
-
Peptide transport by the multidrug resistance protein MRP1
-
de Jong MC, Slootstra JW, Scheffer GL, Schroeijers AB, Puijk WC, Dinkelberg R, Kool M, Broxterman HJ, Meloen RH and Scheper RJ. Peptide transport by the multidrug resistance protein MRP1. Cancer Res. 2001; 61(6):2552-2557.
-
(2001)
Cancer Res.
, vol.61
, Issue.6
, pp. 2552-2557
-
-
de Jong, M.C.1
Slootstra, J.W.2
Scheffer, G.L.3
Schroeijers, A.B.4
Puijk, W.C.5
Dinkelberg, R.6
Kool, M.7
Broxterman, H.J.8
Meloen, R.H.9
Scheper, R.J.10
-
19
-
-
77955712506
-
Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress
-
Ri M, Iida S, Nakashima T, Miyazaki H, Mori F, Ito A, Inagaki A, Kusumoto S, Ishida T, Komatsu H, Shiotsu Y and Ueda R. Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress. Leukemia. 2010; 24(8):1506-1512.
-
(2010)
Leukemia.
, vol.24
, Issue.8
, pp. 1506-1512
-
-
Ri, M.1
Iida, S.2
Nakashima, T.3
Miyazaki, H.4
Mori, F.5
Ito, A.6
Inagaki, A.7
Kusumoto, S.8
Ishida, T.9
Komatsu, H.10
Shiotsu, Y.11
Ueda, R.12
-
20
-
-
67349212864
-
Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells
-
Ruckrich T, Kraus M, Gogel J, Beck A, Ovaa H, Verdoes M, Overkleeft HS, Kalbacher H and Driessen C. Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells. Leukemia. 2009; 23(6):1098-1105.
-
(2009)
Leukemia.
, vol.23
, Issue.6
, pp. 1098-1105
-
-
Ruckrich, T.1
Kraus, M.2
Gogel, J.3
Beck, A.4
Ovaa, H.5
Verdoes, M.6
Overkleeft, H.S.7
Kalbacher, H.8
Driessen, C.9
-
21
-
-
67049107847
-
Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line
-
Lu S, Yang J, Chen Z, Gong S, Zhou H, Xu X and Wang J. Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line. Exp Hematol. 2009; 37(7):831-837.
-
(2009)
Exp Hematol.
, vol.37
, Issue.7
, pp. 831-837
-
-
Lu, S.1
Yang, J.2
Chen, Z.3
Gong, S.4
Zhou, H.5
Xu, X.6
Wang, J.7
-
22
-
-
53049106912
-
Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein
-
Oerlemans R, Franke NE, Assaraf YG, Cloos J, van Zantwijk I, Berkers CR, Scheffer GL, Debipersad K, Vojtekova K, Lemos C, van der Heijden JW, Ylstra B, Peters GJ, Kaspers GL, Dijkmans BA, Scheper RJ, et al. Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. Blood. 2008; 112(6):2489-2499.
-
(2008)
Blood.
, vol.112
, Issue.6
, pp. 2489-2499
-
-
Oerlemans, R.1
Franke, N.E.2
Assaraf, Y.G.3
Cloos, J.4
van Zantwijk, I.5
Berkers, C.R.6
Scheffer, G.L.7
Debipersad, K.8
Vojtekova, K.9
Lemos, C.10
van der Heijden, J.W.11
Ylstra, B.12
Peters, G.J.13
Kaspers, G.L.14
Dijkmans, B.A.15
Scheper, R.J.16
-
23
-
-
52049086674
-
Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/ leukemia cells derived from Jurkat line
-
Lu S, Chen Z, Yang J, Chen L, Gong S, Zhou H, Guo L and Wang J. Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/ leukemia cells derived from Jurkat line. Exp Hematol. 2008; 36(10):1278-1284.
-
(2008)
Exp Hematol.
, vol.36
, Issue.10
, pp. 1278-1284
-
-
Lu, S.1
Chen, Z.2
Yang, J.3
Chen, L.4
Gong, S.5
Zhou, H.6
Guo, L.7
Wang, J.8
-
24
-
-
47949089799
-
Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line
-
Lu S, Yang J, Song X, Gong S, Zhou H, Guo L, Song N, Bao X, Chen P and Wang J. Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line. J Pharmacol Exp Ther. 2008; 326(2):423-431.
-
(2008)
J Pharmacol Exp Ther.
, vol.326
, Issue.2
, pp. 423-431
-
-
Lu, S.1
Yang, J.2
Song, X.3
Gong, S.4
Zhou, H.5
Guo, L.6
Song, N.7
Bao, X.8
Chen, P.9
Wang, J.10
-
25
-
-
33751172982
-
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells
-
Catley L, Weisberg E, Kiziltepe T, Tai YT, Hideshima T, Neri P, Tassone P, Atadja P, Chauhan D, Munshi NC and Anderson KC. Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells. Blood. 2006; 108(10):3441-3449.
-
(2006)
Blood.
, vol.108
, Issue.10
, pp. 3441-3449
-
-
Catley, L.1
Weisberg, E.2
Kiziltepe, T.3
Tai, Y.T.4
Hideshima, T.5
Neri, P.6
Tassone, P.7
Atadja, P.8
Chauhan, D.9
Munshi, N.C.10
Anderson, K.C.11
-
26
-
-
38349105324
-
HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy
-
Carra S, Seguin SJ, Lambert H and Landry J. HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy. J Biol Chem. 2008; 283(3):1437-1444.
-
(2008)
J Biol Chem.
, vol.283
, Issue.3
, pp. 1437-1444
-
-
Carra, S.1
Seguin, S.J.2
Lambert, H.3
Landry, J.4
-
27
-
-
38949184241
-
HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy
-
Carra S, Seguin SJ and Landry J. HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy. Autophagy. 2008; 4(2):237-239.
-
(2008)
Autophagy.
, vol.4
, Issue.2
, pp. 237-239
-
-
Carra, S.1
Seguin, S.J.2
Landry, J.3
-
28
-
-
0034717110
-
Regulation of [Ca(2+)](i) homeostasis in MRP1 overexpressing cells
-
Filipeanu CM, Nelemans A, Veldman RJ, de Zeeuw D and Kok JW. Regulation of [Ca(2+)](i) homeostasis in MRP1 overexpressing cells. FEBS Lett. 2000; 474(1):107-110.
-
(2000)
FEBS Lett.
, vol.474
, Issue.1
, pp. 107-110
-
-
Filipeanu, C.M.1
Nelemans, A.2
Veldman, R.J.3
de Zeeuw, D.4
Kok, J.W.5
-
29
-
-
0036206470
-
Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistanceassociated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT)
-
Guo A, Marinaro W, Hu P and Sinko PJ. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistanceassociated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT). Drug Metab Dispos. 2002; 30(4):457-463.
-
(2002)
Drug Metab Dispos.
, vol.30
, Issue.4
, pp. 457-463
-
-
Guo, A.1
Marinaro, W.2
Hu, P.3
Sinko, P.J.4
-
30
-
-
38149082008
-
Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells
-
Fuchs D, Berges C, Opelz G, Daniel V and Naujokat C. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem. 2008; 103(1):270-283.
-
(2008)
J Cell Biochem.
, vol.103
, Issue.1
, pp. 270-283
-
-
Fuchs, D.1
Berges, C.2
Opelz, G.3
Daniel, V.4
Naujokat, C.5
-
31
-
-
79951494668
-
Initial genome sequencing and analysis of multiple myeloma
-
Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet JP, Ahmann GJ, Adli M, Anderson KC, Ardlie KG, Auclair D, Baker A, Bergsagel PL, Bernstein BE, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011; 471(7339):467-472.
-
(2011)
Nature.
, vol.471
, Issue.7339
, pp. 467-472
-
-
Chapman, M.A.1
Lawrence, M.S.2
Keats, J.J.3
Cibulskis, K.4
Sougnez, C.5
Schinzel, A.C.6
Harview, C.L.7
Brunet, J.P.8
Ahmann, G.J.9
Adli, M.10
Anderson, K.C.11
Ardlie, K.G.12
Auclair, D.13
Baker, A.14
Bergsagel, P.L.15
Bernstein, B.E.16
-
32
-
-
84870483290
-
Sequence analysis of betasubunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone
-
Lichter DI, Danaee H, Pickard MD, Tayber O, Sintchak M, Shi H, Richardson PG, Cavenagh J, Blade J, Facon T, Niesvizky R, Alsina M, Dalton W, Sonneveld P, Lonial S, van de Velde H, et al. Sequence analysis of betasubunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone. Blood. 2012; 120(23):4513-4516.
-
(2012)
Blood.
, vol.120
, Issue.23
, pp. 4513-4516
-
-
Lichter, D.I.1
Danaee, H.2
Pickard, M.D.3
Tayber, O.4
Sintchak, M.5
Shi, H.6
Richardson, P.G.7
Cavenagh, J.8
Blade, J.9
Facon, T.10
Niesvizky, R.11
Alsina, M.12
Dalton, W.13
Sonneveld, P.14
Lonial, S.15
van de Velde, H.16
-
33
-
-
28844435438
-
No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to Bortezomib
-
Politou M, Karadimitris A, Terpos E, Kotsianidis I, Apperley JF and Rahemtulla A. No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to Bortezomib. Leuk Res. 2006; 30(2):240-241.
-
(2006)
Leuk Res.
, vol.30
, Issue.2
, pp. 240-241
-
-
Politou, M.1
Karadimitris, A.2
Terpos, E.3
Kotsianidis, I.4
Apperley, J.F.5
Rahemtulla, A.6
-
34
-
-
50349101943
-
Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics
-
Wang L, Kumar S, Fridley BL, Kalari KR, Moon I, Pelleymounter LL, Hildebrandt MA, Batzler A, Eckloff BW, Wieben ED and Greipp PR. Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics. Clin Cancer Res. 2008; 14(11):3503-3513.
-
(2008)
Clin Cancer Res.
, vol.14
, Issue.11
, pp. 3503-3513
-
-
Wang, L.1
Kumar, S.2
Fridley, B.L.3
Kalari, K.R.4
Moon, I.5
Pelleymounter, L.L.6
Hildebrandt, M.A.7
Batzler, A.8
Eckloff, B.W.9
Wieben, E.D.10
Greipp, P.R.11
-
35
-
-
84878322959
-
Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
-
Kraus M, Bader J, Overkleeft H and Driessen C. Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance. Blood Cancer J. 2013; 3:e103.
-
(2013)
Blood Cancer J.
, vol.3
-
-
Kraus, M.1
Bader, J.2
Overkleeft, H.3
Driessen, C.4
-
36
-
-
0032499199
-
A proteolytic system that compensates for loss of proteasome function
-
Glas R, Bogyo M, McMaster JS, Gaczynska M and Ploegh HL. A proteolytic system that compensates for loss of proteasome function. Nature. 1998; 392(6676):618-622.
-
(1998)
Nature.
, vol.392
, Issue.6676
, pp. 618-622
-
-
Glas, R.1
Bogyo, M.2
McMaster, J.S.3
Gaczynska, M.4
Ploegh, H.L.5
-
37
-
-
77953229918
-
Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy
-
Wu WK, Sakamoto KM, Milani M, Aldana-Masankgay G, Fan D, Wu K, Lee CW, Cho CH, Yu J and Sung JJ. Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy. Drug Resist Updat. 2010; 13(3):87-92.
-
(2010)
Drug Resist Updat.
, vol.13
, Issue.3
, pp. 87-92
-
-
Wu, W.K.1
Sakamoto, K.M.2
Milani, M.3
Aldana-Masankgay, G.4
Fan, D.5
Wu, K.6
Lee, C.W.7
Cho, C.H.8
Yu, J.9
Sung, J.J.10
-
38
-
-
79952016563
-
Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagylysosome and ER stress
-
Kawaguchi T, Miyazawa K, Moriya S, Ohtomo T, Che XF, Naito M, Itoh M and Tomoda A. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagylysosome and ER stress. Int J Oncol. 2011; 38(3):643-654.
-
(2011)
Int J Oncol.
, vol.38
, Issue.3
, pp. 643-654
-
-
Kawaguchi, T.1
Miyazawa, K.2
Moriya, S.3
Ohtomo, T.4
Che, X.F.5
Naito, M.6
Itoh, M.7
Tomoda, A.8
-
39
-
-
78650041246
-
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes
-
David E, Kaufman JL, Flowers CR, Schafer-Hales K, Torre C, Chen J, Marcus AI, Sun SY, Boise LH and Lonial S. Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes. Blood. 2010; 116(24):5285-5288.
-
(2010)
Blood.
, vol.116
, Issue.24
, pp. 5285-5288
-
-
David, E.1
Kaufman, J.L.2
Flowers, C.R.3
Schafer-Hales, K.4
Torre, C.5
Chen, J.6
Marcus, A.I.7
Sun, S.Y.8
Boise, L.H.9
Lonial, S.10
-
40
-
-
0037040541
-
Molecular chaperones in the cytosol: from nascent chain to folded protein
-
Hartl FU and Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science. 2002; 295(5561):1852-1858.
-
(2002)
Science.
, vol.295
, Issue.5561
, pp. 1852-1858
-
-
Hartl, F.U.1
Hayer-Hartl, M.2
-
41
-
-
4344578534
-
The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator
-
Alberti S, Bohse K, Arndt V, Schmitz A and Hohfeld J. The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator. Mol Biol Cell. 2004; 15(9):4003-4010.
-
(2004)
Mol Biol Cell.
, vol.15
, Issue.9
, pp. 4003-4010
-
-
Alberti, S.1
Bohse, K.2
Arndt, V.3
Schmitz, A.4
Hohfeld, J.5
-
42
-
-
79959939343
-
BAG3 and friends: co-chaperones in selective autophagy during aging and disease
-
Behl C. BAG3 and friends: co-chaperones in selective autophagy during aging and disease. Autophagy. 2011; 7(7):795-798.
-
(2011)
Autophagy.
, vol.7
, Issue.7
, pp. 795-798
-
-
Behl, C.1
-
43
-
-
84861362268
-
NF-kappaB regulates protein quality control after heat stress through modulation of the BAG3-HspB8 complex
-
Nivon M, Abou-Samra M, Richet E, Guyot B, Arrigo AP and Kretz-Remy C. NF-kappaB regulates protein quality control after heat stress through modulation of the BAG3-HspB8 complex. J Cell Sci. 2012; 125(Pt 5):1141-1151.
-
(2012)
J Cell Sci.
, vol.125
, Issue.PT. 5
, pp. 1141-1151
-
-
Nivon, M.1
Abou-Samra, M.2
Richet, E.3
Guyot, B.4
Arrigo, A.P.5
Kretz-Remy, C.6
-
44
-
-
23844516979
-
Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and proapoptotic transcriptional responses: a microarray analysis
-
Yew EH, Cheung NS, Choy MS, Qi RZ, Lee AY, Peng ZF, Melendez AJ, Manikandan J, Koay ES, Chiu LL, Ng WL, Whiteman M, Kandiah J and Halliwell B. Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and proapoptotic transcriptional responses: a microarray analysis. J Neurochem. 2005; 94(4):943-956.
-
(2005)
J Neurochem.
, vol.94
, Issue.4
, pp. 943-956
-
-
Yew, E.H.1
Cheung, N.S.2
Choy, M.S.3
Qi, R.Z.4
Lee, A.Y.5
Peng, Z.F.6
Melendez, A.J.7
Manikandan, J.8
Koay, E.S.9
Chiu, L.L.10
Ng, W.L.11
Whiteman, M.12
Kandiah, J.13
Halliwell, B.14
-
45
-
-
2642539919
-
Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy
-
Irobi J, Van Impe K, Seeman P, Jordanova A, Dierick I, Verpoorten N, Michalik A, De Vriendt E, Jacobs A, Van Gerwen V, Vennekens K, Mazanec R, Tournev I, Hilton-Jones D, Talbot K, Kremensky I, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet. 2004; 36(6):597-601.
-
(2004)
Nat Genet.
, vol.36
, Issue.6
, pp. 597-601
-
-
Irobi, J.1
Van Impe, K.2
Seeman, P.3
Jordanova, A.4
Dierick, I.5
Verpoorten, N.6
Michalik, A.7
De Vriendt, E.8
Jacobs, A.9
Van Gerwen, V.10
Vennekens, K.11
Mazanec, R.12
Tournev, I.13
Hilton-Jones, D.14
Talbot, K.15
Kremensky, I.16
-
46
-
-
21244489544
-
HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells
-
Carra S, Sivilotti M, Chavez Zobel AT, Lambert H and Landry J. HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells. Hum Mol Genet. 2005; 14(12):1659-1669.
-
(2005)
Hum Mol Genet.
, vol.14
, Issue.12
, pp. 1659-1669
-
-
Carra, S.1
Sivilotti, M.2
Chavez Zobel, A.T.3
Lambert, H.4
Landry, J.5
-
47
-
-
77955365630
-
The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS)
-
Crippa V, Sau D, Rusmini P, Boncoraglio A, Onesto E, Bolzoni E, Galbiati M, Fontana E, Marino M, Carra S, Bendotti C, De Biasi S and Poletti A. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet. 2010; 19(17):3440-3456.
-
(2010)
Hum Mol Genet.
, vol.19
, Issue.17
, pp. 3440-3456
-
-
Crippa, V.1
Sau, D.2
Rusmini, P.3
Boncoraglio, A.4
Onesto, E.5
Bolzoni, E.6
Galbiati, M.7
Fontana, E.8
Marino, M.9
Carra, S.10
Bendotti, C.11
De Biasi, S.12
Poletti, A.13
-
49
-
-
84862275104
-
The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic cell death
-
Robert G, Gastaldi C, Puissant A, Hamouda A, Jacquel A, Dufies M, Belhacene N, Colosetti P, Reed JC, Auberger P and Luciano F. The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic cell death. Autophagy. 2012; 8(4):637-649.
-
(2012)
Autophagy.
, vol.8
, Issue.4
, pp. 637-649
-
-
Robert, G.1
Gastaldi, C.2
Puissant, A.3
Hamouda, A.4
Jacquel, A.5
Dufies, M.6
Belhacene, N.7
Colosetti, P.8
Reed, J.C.9
Auberger, P.10
Luciano, F.11
|